ArticleInterdisciplinary sciences, computational life sciences2026
EMMVEP: An Ensemble Method for Protein Missense Variant Effect Prediction Based on Multi-Source Feature Fusion.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Missense mutations are common in the coding genome and can alter protein functions. Distinguishing pathogenic from benign variants remains challenging despite computational advances. In the present work, we introduce EMMVEP, an ensemble-based approach designed for predicting the effects of protein missense mutations. EMMVEP leverages categorical boosting to integrate different types of features: one-hot encoding from protein sequence, physicochemical and environment properties extracted from AlphaFold database, and allele frequency information from gnomAD. When evaluated on a benchmark dataset with 112,832 clinical significance labels, our method achieved AUC and AUPR of 0.907 and 0.879, outperforming 20 general VEP methods. To aid in the identification of pathogenic mutations among the vast number of rare variants discovered through large-scale sequencing studies, we provide the pathogenicity probabilities of 216 million potential amino acid substitutions in 19,233 human protein-encoding genes. Our work demonstrates that EMMVEP can offer valuable independent insights for missense mutation interpretation in proteins, with significant applicability in both research and clinical contexts.
Indexed as
Identifiers
41758278What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.